Moreover, the evidence from preliminary results on the efficacy of the aforementioned new strategies in MM relapsed/refractory MM patients support the assumption that VEGF/VEGFR inhibition represents a useful strategy in the treatment of MM patients. Here, VEGFA is linked to Miyoshi myopathy.